CRMD (Cormedix) Short Interest


CRMD Cormedix Inc CRMD
39 GF Score
Price $7.72
GF Value $66.53
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cormedix Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CRMD vs DSGN, SGP, PRME: Short Interest Comparison

For the Biotechnology subindustry, Cormedix's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cormedix Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cormedix's Short Interest distribution charts can be found below:

* The bar in red indicates where Cormedix's Short Interest falls into.


CRMD
39GF Score
Cormedix Inc CRMD
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cormedix (CRMD) Overvalued in 2026?

Based on GuruFocus' analysis, Cormedix stock appears to be undervalued. The current stock price of $7.72 is trading 88.4% below its estimated GF Value™ of $66.53. GuruFocus considers Cormedix to be Possible Value Trap.

Key valuation signals for CRMD:

  • Short Interest:
  • GF Value™: $66.53 vs. price of $7.72 (88.4% below fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the CRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cormedix Business Description

Other Exchanges 19KA:Germany
Address 389 Interpace Parkway, Suite 450, Parsippany, NJ, USA, 07054
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
39GF Score

Get the complete analysis for CRMD

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.72
Price
$66.53
GF Value